- Title
- Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein
- Creators
- Rachel NeMoyer - New Brunswick, NJ 08903 USAArindam Mondal - New Brunswick, NJ 08903 USAMehul Vora - Piscataway, NJ 08854 USAElaine Langenfeld - New Brunswick, NJ 08903 USADanea Glover - Piscataway, NJ 08854 USAMichael Scott - New Brunswick, NJ 08903 USALauren Lairson - Piscataway, NJ 08854 USAChristopher Rongo - Piscataway, NJ 08854 USADavid J Augeri - Piscataway, NJ 08854 USAYouyi Peng - New Brunswick, NJ 08903 USASalma K Jabbour - New Brunswick, NJ 08903 USAJohn Langenfeld - New Brunswick, NJ 08903 USA
- Publication Details
- Cell communication and signaling, Vol.17(1), pp.150-150
- Date published
- 11/19/2019
- Publisher
- BioMed Central
- Grant note
- R01 CA225830-01A1 / ;
- Academic Unit
- Biomedical Informatics; Medicinal Chemistry (EMSOP); Waksman Institute of Microbiology; Genetics (SAS); Molecular Biology and Biochemistry (SAS); Surgery - Cardiothoracic Surgery (RWJMS); Clinical Radiation Oncology
- Language
- English
- Resource Type
- Journal article
- Identifiers
- 991031654761704646
Journal article
Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein
Cell communication and signaling, Vol.17(1), pp.150-150
11/19/2019
PMCID: PMC6862756
PMID: 31744505
Metrics
8 Record Views